AXIM BIOTECHNOLOGIES, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$150.41 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$59.75K, a 1054.41% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $6.26K.
- AXIM BIOTECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-03-31 was -$44.92K.
- AXIM BIOTECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2021-03-31 was -$7.97K.
- AXIM BIOTECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $109.17K.
- AXIM BIOTECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$405.68K.
- AXIM BIOTECHNOLOGIES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was -$4.22K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$150.41K 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | -$59.75K 10-Q/A · filed 2024-05-22 | |||
| 2023-12-31 | $109.17K 10-K · filed 2024-04-16 | |||
| 2023-09-30 | -$24.06K 10-Q · filed 2023-11-20 | |||
| 2023-06-30 | $50.22K 10-Q · filed 2024-08-19 | |||
| 2023-03-31 | $6.26K 10-Q/A · filed 2024-05-22 | |||
| 2022-12-31 | -$405.68K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$289.22K 10-Q · filed 2023-11-20 | |||
| 2022-06-30 | -$387.80K 10-Q · filed 2023-08-21 | |||
| 2022-03-31 | -$44.92K 10-Q · filed 2023-05-22 | |||
| 2021-12-31 | -$4.22K 10-K · filed 2023-04-17 | |||
| 2021-09-30 | -$118.80K 10-Q/A · filed 2022-11-15 | |||
| 2021-06-30 | -$255.00K 10-Q · filed 2022-08-16 | |||
| 2021-03-31 | -$7.97K 10-Q · filed 2022-05-23 | |||
| 2020-09-30 | $645.61K 10-Q · filed 2021-11-22 | |||
| 2020-06-30 | $379.80K 10-Q · filed 2021-08-23 |